Atara Biotherapeutics Reports Collaborators At Memorial Sloan Kettering Cancer Center Presented Updated Results From Ongoing MSK Phase 1 Study Of Mesothelin-Targeted CAR T Immunotherapy
Benzinga Newsdesk